NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/18/2026 12:53
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization70.58 mln
Float6.08 mln
Earnings Date09/14/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.72
Highly reliable
Relative Strength
20
/ 100
Significantly lagging
Debt / Equity
1.14
Elevated leverage
ROE
-53.79
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Champions Oncology is a US-based research company that helps pharmaceutical and biotechnology firms develop cancer drugs by implanting human tumors into specially bred mice, allowing scientists to study how those tumors respond to treatment. The company also offers Lumin Bioinformatics, a software tool that pulls together data from research and clinical studies to support drug development decisions. Founded in 1985 and based in Hackensack, New Jersey, Champions Oncology reaches its clients through online channels and a dedicated sales team.
